Animal Products
Species for a Product
Product Image
Product CodeUnit PackageCase Size
1GAM001100 mL12

Category: Antimicrobial

Species: Cattle, Sheep, Pigs

Active Ingredients: gamithromycin

Legal Category: POM-V

Downloads
BIOEQUIVALENT TO ZACTRAN®

What is Gamrozyne™?

Introducing fast-acting Gamrozyne™, the first and only bioequivalent to Zactran (gamithromycin) for the treatment and metaphylaxis of Bovine Respiratory Disease (BRD), treatment of Swine Respiratory Disease (SRD) and treatment of foot rot in sheep.

gamrozyne logo

Indications

Cattle
Treatment and metaphylaxis of bovine respiratory disease (BRD) associated with Histophilus somni, Mannheimia haemolytica and Pasteurella multocida.
The presence of the disease in the group should be established before the product is used.

Pigs
Treatment of swine respiratory disease (SRD) associated with Actinobacillus pleuropneumoniae, Bordetella bronchiseptica, Glaesserella parasuis, and Pasteurella multocida.

Sheep
Treatment of infectious pododermatitis (foot rot) associated with virulent Dichelobacter nodosus and Fusobacterium necrophorum requiring systemic treatment.

Why Gamrozyne?

  • FAST
    Reaches target tissue in 30 minutes.
  • TARGETED
    Concentrates in cattle & pig respiratory tissue for proven efficacy against respiratory disease. Concentrates in sheep skin tissue for targeted treatment of foot rot.
  • CONVENIENT
    Reassurance of long acting activity.

Withdrawal Period

Cattle
Meat and offal: 64 days.
Not authorised for use in animals producing milk for human consumption.
Do not use in pregnant animals which are intended to produce milk for human consumption within 2 months of expected parturition.

Sheep:
Meat and offal: 29 days.
Not authorised for use in animals producing milk for human consumption.
Do not use in pregnant animals which are intended to produce milk for human consumption within 1 month of expected parturition.

Pigs:
Meat and offal: 16 days.


Gamrozyne 150 mg/ml Solution for Injection for Cattle, Sheep and Pigs is a POM-V medicine containing 150mg/ml gamithromycin. For full production indications and information, see the SPC available on the VMD website. Prescription decisions are for the person issuing the prescription alone.  Date page created: October 2026. Bimeda can be contacted on 01248 725 400 or This email address is being protected from spambots. You need JavaScript enabled to view it.. Use Medicines Responsibly. Noah.co.uk/responsible.

Prescription decisions are for the prescriber only. Advice should be sought from the presciber.